Search

Bioactive peptides are protein fragments that have a positive impact on body functions and may ultimately influence health. Angiotensin-converting enzyme plays an important role in the control of arterial blood pressure. The main action of Angiotensin II is to maintain blood pressure and fluid balance in the body. It is obtained from the precursor under catalytic action of angiotensin-converting enzyme (ACE). In order to control (inhibit) the action of the ACE different inhibitors were proposed and some of them are already in use in the clinic. In the present investigation we design and docking studies of fife new potential ACE inhibitors. Three of the proposed analogues have a potential to be ACE inhibitors, as they bind to the enzyme stronger than His-Leu. The studied peptides may form as a basis for the design of new compounds and will be synthesized and biologically tested. [ABSTRACT FROM AUTHOR]

Leu-Arg is a kyotorphin receptor antagonist. It is very important to control antinociception and this could be achieved by modifications in agonist's or antagonist's molecules. Two analogues of Leu-Arg were synthesized, their IR- spectral characteristics were defined, and preliminary docking studies were performed. The results show that new analogues bind receptor thus they could be used for further analysis and their biological activity could be tested in vitro and in vivo. [ABSTRACT FROM AUTHOR]